Person

Daniel Gesua Sive Salvadori

EVP AND GROUP PRESIDENT, Abbott Laboratories

Current S&P 500 boards
0
Current roles
1
Open-market buys
$0
Open-market sales
$46.6M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Mar 2, 2026ABTSale885$115.58$102K
Jan 30, 2025ABTSale23,771$128.50$3.1M
Mar 1, 2024ABTSale963$118.50$114K
Mar 1, 2023ABTSale1,085$100.70$109K
Mar 1, 2022ABTSale1,550$118.17$183K
Dec 23, 2021ABTSale58,501$140.00$8.2M
Dec 13, 2021ABTSale3,499$135.00$472K
Dec 13, 2021ABTSale55,000$135.00$7.4M
Mar 1, 2021ABTSale1,664$120.61$201K
Aug 27, 2020ABTSale42,479$111.86$4.8M
Mar 2, 2020ABTSale999$77.89$78K
Jun 26, 2019ABTSale71,000$84.00$6.0M
Jun 13, 2019ABTSale3,331$82.00$273K
Jun 11, 2019ABTSale7,269$82.00$596K
Mar 1, 2019ABTSale1,664$78.00$130K
Sep 28, 2018ABTSale200$73.40$15K
Sep 28, 2018ABTSale4,800$73.39$352K
May 18, 2018ABTSale1,000$61.50$62K
May 17, 2018ABTSale2,000$61.05$122K
Mar 1, 2018ABTSale905$58.97$53K
Dec 14, 2017ABTSale9,839$54.90$540K
Dec 14, 2017ABTSale1,483$54.91$81K
Dec 14, 2017ABTSale200$54.91$11K
Dec 14, 2017ABTSale200$54.92$11K
Dec 14, 2017ABTSale1,900$54.92$104K
Dec 14, 2017ABTSale100$54.92$5K
Dec 14, 2017ABTSale6,897$54.93$379K
Dec 14, 2017ABTSale7,700$54.94$423K
Nov 14, 2017ABTSale71,157$55.00$3.9M
Oct 23, 2017ABTSale96,603$56.21$5.4M
Sep 26, 2017ABTSale62,460$52.95$3.3M
Mar 1, 2017ABTSale2,066$45.39$94K
Sep 26, 2016ABTSale815$41.71$34K
Feb 29, 2016ABTSale700$39.26$27K
Feb 29, 2016ABTSale81$39.26$3K
Feb 29, 2016ABTSale100$39.27$4K

SEC reporting-owner ID (CIK) 1620564 · all filings on EDGAR